Antitubercular Bis-Substituted Cyclam Derivatives: Structure-Activity Relationships and in Vivo Studies. 2018

Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia.

We recently reported the discovery of nontoxic cyclam-derived compounds that are active against drug-resistant Mycobacterium tuberculosis. In this paper we report exploration of the structure-activity relationship for this class of compounds, identifying several simpler compounds with comparable activity. The most promising compound identified, possessing significantly improved water solubility, displayed high levels of bacterial clearance in an in vivo zebrafish embryo model, suggesting this compound series has promise for in vivo treatment of tuberculosis.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006573 Heterocyclic Compounds, 1-Ring Organic compounds that contain a ring structure made up of carbon and one or more additional elements such as nitrogen and oxygen. Heterocyclic Cpds, 1-Ring,1-Ring Heterocyclic Compounds,1-Ring Heterocyclic Cpds,Heterocyclic Compounds, 1 Ring,Heterocyclic Cpds, 1 Ring
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001372 Aza Compounds Organic chemicals where carbon atoms have been replaced by nitrogen atoms. Compounds, Aza
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D015027 Zebrafish An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research. Brachydanio rerio,Danio rerio,B. rerio,D. rerio,Zebra Fish,Zebra Fishes,Zebra danio,Zebrafishes,D. rerios,Fishes, Zebra,Zebra danios,danio, Zebra
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
November 2019, Antibiotics (Basel, Switzerland),
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
January 2014, European journal of medicinal chemistry,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
November 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
September 1977, The Journal of antibiotics,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
April 1957, The Journal of pharmacology and experimental therapeutics,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
October 2022, RSC medicinal chemistry,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
June 2007, Natural product research,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
September 1975, Archiv der Pharmazie,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
September 2005, Cancer chemotherapy and pharmacology,
Malcolm Spain, and Joseph K-H Wong, and Gayathri Nagalingam, and James M Batten, and Elinor Hortle, and Stefan H Oehlers, and Xiao Fan Jiang, and Hasini E Murage, and Jack T Orford, and Patrick Crisologo, and James A Triccas, and Peter J Rutledge, and Matthew H Todd
October 2010, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!